Personalised medicine aims to provide the right treatment to the right patient, at the right dose and at the right time. this paper discusses how the regulatory process for companion diagnostics might be improved to realise the potential of personalised medicine.
Eric Lawson, Linda Lebon, Anne Virginie Eggimann, Anne Dupraz-Poiseau
Activities to improve the regulatory framework for companion diagnostics step up
2010 – SCRIP Regulatory Affairs
Download the full publication now
Fill in the form to download the content
All our resources 
